Hepatic Complications

Relevant Chapters

• HIV -  Hepatic Disease in Patients With HIV

Relevant Pages in Other Chapters

HIV - Epidemiology of HIV Infection in the Developed World

• Liver Disease

HIV - Agents Used in Antiretroviral Therapy

• Tipranavir
• Nevirapine

HIV - Endocrine Disorders: Evaluation and Management

• When to Refer to a Diabetologist
• T₄
• Sulfonylureas for Diabetes
• Thiazolidinediones for Diabetes

HIV - Key Principles and Recommended Regimens for First-line Antiretroviral Therapy

• Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Coformulated Regimen vs Boosted PIs in Treatment-Naive Patients

HIV - Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy

• Treatment Complications

HIV - Special Considerations Related to Aging in Persons With HIV

• Other Comorbidities

HIV - Management of Bone Disease and Body Composition Changes

• Lactic Acidosis

Guidelines

• British HIV Association Guidelines for Treatment and Management of HIV and Hepatitis C Coinfection
• Care of HIV Patients with Chronic Hepatitis B: Updated Recommendations from the HIV-Hepatitis B Virus International Panel
• Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel
• EASL Clinical Practical Guidelines: Management of Alcohol-Related Liver Disease
• EASL–EASD–EASO Clinical Practice Guidelines for the Management of Non-alcoholic Fatty Liver Disease
• European Guidelines for Treatment of HIV-Infected Adults in Europe: Part IV Clinical Management and Treatment of Chronic HBV and HCV Coinfection in HIV-Positive Persons
• European Guidelines for Treatment of HIV-Infected Adults in Europe: Part IV Clinical Management and Treatment of Chronic HBV and HCV Coinfection in HIV-Positive Persons
• European Guidelines for Treatment of HIV-Infected Adults in Europe—Part III Guidelines for the Prevention and Management of Comorbidities in HIV-Positive Persons
• Management of Hepatitis Viruses in Adults Infected With HIV
• The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases
• Update: Adverse Event Data and Revised Recommendations Against Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection